Cubist Systematic Strategies’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-38,005
| Closed | -$68K | – | 3765 |
|
|
2022
Q3 | $68K | Sell |
38,005
-566
| -1% | -$1.01K | ﹤0.01% | 3287 |
|
|
2022
Q2 | $112K | Sell |
38,571
-25,940
| -40% | -$75.3K | ﹤0.01% | 3398 |
|
|
2022
Q1 | $178K | Sell |
64,511
-34,294
| -35% | -$94.6K | ﹤0.01% | 3061 |
|
|
2021
Q4 | $460K | Buy |
98,805
+32,078
| +48% | +$149K | ﹤0.01% | 2505 |
|
|
2021
Q3 | $568K | Buy |
66,727
+35,298
| +112% | +$300K | 0.01% | 1947 |
|
|
2021
Q2 | $516K | Buy |
31,429
+835
| +3% | +$13.7K | 0.01% | 1990 |
|
|
2021
Q1 | $676K | Buy |
30,594
+22,857
| +295% | +$505K | 0.01% | 1785 |
|
|
2020
Q4 | $239K | Buy |
+7,737
| New | +$239K | ﹤0.01% | 2147 |
|